LexCase regularly publishes articles on the most relevant news, be it regulations, case law or various opinions.
I RANKING I LexCase’s Healthcare team has once again been ranked among the best in Tier 2 in The Legal 500EMEA (Legalease) in the Industry Focus: Healthcare and Life Sciences category.
FLASH LIFE SCIENCE – Renewal of the Cooperation Protocol between the ANSM and the DGCCRF
![[DISTINCTION] Diane BANDON TOURET once again recognized as a “Stand-out Lawyer” by Thomson Reuters for 2026](https://lexcase.com/wp-content/uploads/2026/02/Distinctions-2-365x120.png)
[DISTINCTION] Diane BANDON TOURET once again recognized as a “Stand-out Lawyer” by Thomson Reuters for 2026
| RANKING | Diane BANDON-TOURRET and the Healthcare Industries Department Recognized Once Again in the Chambers and Partners 2026 Ranking
[HEALTH PRODUCTS INDUSTRIES] The contributions of decree no. 2025-895 of September 4, 2025 relating to the experimentation of the reprocessing of certain single-use medical devices
I PUBLICATION I The Lexcase Health Law Department authors the France chapter of Chambers and Partners – Product Liability & Safety 2025 Guide
[DISTINCTION] Diane BANDON TOURET once again recognized as a “Stand-out Lawyer” by Thomson Reuters for 2026
![[DISTINCTION] Diane BANDON TOURET once again recognized as a “Stand-out Lawyer” by Thomson Reuters for 2026](https://lexcase.com/wp-content/uploads/2026/02/Distinctions-2-1135x450.png)
LexCase’s Healthcare Products & Industries practice receives international recognition.
We are delighted to announce that Diane BANDON TOURET, head of the Healthcare Products & Industries Department, has once again been named a “Stand-out Lawyer” by Thomson Reuters in its 2026 annual rankings.
This recognition highlights her expertise and commitment in supporting clients through their most complex challenges, particularly in international projects.
We thank Thomson Reuters for this renewed recognition, as well as our clients and partners for their continued trust.
This distinction reinforces our commitment to remain a leading player in the healthcare industry. We will continue to defend your interests with rigor and transparency, while supporting you in your most ambitious projects.